Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Qing-Xin-Jiao-Tai Decoction for Insomnia and Obesity
NCT07754383Phase 1Not yet recruiting
- Sponsor
- FOHOW Group
- Start
- Oct 2026
- Primary completion
- Oct 2028
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in Insomnia and obesity (2 arms), sponsored by FOHOW Group. Primary endpoints: Body Weight at 12 weeks, Body Fat Percentage Assessed by Bioelectrical Impedance Analysis (BIA) at 12 weeks and 6 more. Planned start Oct 2026; status: not yet recruiting.
02
Conditions
Insomniaobesity
Beyond the preview
Go deeper on NCT07754383.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07754383.